Novo Integrated Sciences, Inc. (NVOS)

Market Cap	12.44M
Revenue (ttm)	13.52M
Net Income (ttm)	-24.33M
Shares Out	19.05M
EPS (ttm)	-1.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	393,273
Open	0.645
Previous Close	0.640
Day's Range	0.636 - 0.680
52-Week Range	0.416 - 5.380
Beta	-0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 19, 2024

About NVOS

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline test...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Sep 22, 2017
• Employees: 230
• Stock Exchange: NASDAQ
• Ticker Symbol: NVOS

Financial Performance

In 2023, NVOS's revenue was $12.57 million, an increase of 7.11% compared to the previous year's $11.74 million. Losses were -$13.21 million, -59.77% less than in 2022.